Last reviewed · How we verify
MediCabilis CBD Oil
CBD (cannabidiol) modulates endocannabinoid system signaling and interacts with multiple receptors to produce anti-inflammatory, anxiolytic, and analgesic effects.
CBD (cannabidiol) modulates endocannabinoid system signaling and interacts with multiple receptors to produce anti-inflammatory, anxiolytic, and analgesic effects. Used for Chronic pain, Anxiety, Epilepsy (seizure disorders).
At a glance
| Generic name | MediCabilis CBD Oil |
|---|---|
| Sponsor | Gold Coast Hospital and Health Service |
| Drug class | Cannabinoid |
| Target | CB1 receptor, CB2 receptor, 5-HT1A receptor, TRPV1 receptor (multiple targets) |
| Modality | Small molecule |
| Therapeutic area | Neurology, Pain Management, Psychiatry |
| Phase | FDA-approved |
Mechanism of action
Cannabidiol acts as a negative allosteric modulator of CB1 and CB2 receptors and interacts with serotonin (5-HT1A), vanilloid (TRPV1), and other receptors to reduce inflammation, anxiety, and pain signaling. The exact mechanisms vary by indication and are not fully elucidated, but CBD does not produce the psychoactive effects associated with THC.
Approved indications
- Chronic pain
- Anxiety
- Epilepsy (seizure disorders)
- Inflammation-related conditions
Common side effects
- Drowsiness
- Fatigue
- Diarrhea
- Changes in appetite
- Headache
Key clinical trials
- Efficacy of Cannabinoids in Amyotrophic Lateral Sclerosis or Motor Neurone Disease (PHASE3)
- EMERALD TRIAL Open Label Extension Study (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- MediCabilis CBD Oil CI brief — competitive landscape report
- MediCabilis CBD Oil updates RSS · CI watch RSS
- Gold Coast Hospital and Health Service portfolio CI